195 related articles for article (PubMed ID: 25171823)
1. Public perceptions of presymptomatic testing for Alzheimer disease.
Caselli RJ; Langbaum J; Marchant GE; Lindor RA; Hunt KS; Henslin BR; Dueck AC; Robert JS
Mayo Clin Proc; 2014 Oct; 89(10):1389-96. PubMed ID: 25171823
[TBL] [Abstract][Full Text] [Related]
2. [Attitudes towards predictive genetic testing for Alzheimer's disease].
Illes F; Bernhardt T; Prell K; Rietz C; Rudinger G; Frölich L; Maier W; Rietschel M
Z Gerontol Geriatr; 2006 Jun; 39(3):233-9. PubMed ID: 16794889
[TBL] [Abstract][Full Text] [Related]
3. Attitudes and knowledge about presymptomatic genetic testing among individuals at high risk for familial, early-onset Alzheimer's disease.
Marcheco B; Bertoli AM; Rojas I; Heredero L
Genet Test; 2003; 7(1):45-7. PubMed ID: 12820702
[TBL] [Abstract][Full Text] [Related]
4. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study.
Weston PSJ; Nicholas JM; Henley SMD; Liang Y; Macpherson K; Donnachie E; Schott JM; Rossor MN; Crutch SJ; Butler CR; Zeman AZ; Fox NC
Lancet Neurol; 2018 Feb; 17(2):123-132. PubMed ID: 29413314
[TBL] [Abstract][Full Text] [Related]
5. To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk.
Rahman B; Meiser B; Sachdev P; Barlow-Stewart K; Otlowski M; Zilliacus E; Schofield P
Genet Test Mol Biomarkers; 2012 Aug; 16(8):935-42. PubMed ID: 22731638
[TBL] [Abstract][Full Text] [Related]
6. Attitudes to Alzheimer's disease testing of Australian general practice patients: a cross-sectional questionnaire-based study.
Magin P; Juratowitch L; Dunbabin J; McElduff P; Goode S; Tapley A; Pond D
Int J Geriatr Psychiatry; 2016 Apr; 31(4):361-6. PubMed ID: 26258761
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer Disease Worries, Fears, and Stigma and Their Relationship to Genetic and Interventional Research Engagement.
Bardach SH; Kent S; Jicha GA
Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):75-79. PubMed ID: 32960855
[TBL] [Abstract][Full Text] [Related]
8. Reacting to genetic risk: an experimental survey of life between health and disease.
Almeling R; Gadarian SK
J Health Soc Behav; 2014 Dec; 55(4):482-503. PubMed ID: 25413807
[TBL] [Abstract][Full Text] [Related]
9. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
[TBL] [Abstract][Full Text] [Related]
10. Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility.
Kopits IM; Chen C; Roberts JS; Uhlmann W; Green RC
Genet Test Mol Biomarkers; 2011 Dec; 15(12):871-5. PubMed ID: 21749214
[TBL] [Abstract][Full Text] [Related]
11. Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing.
Rodrigues CS; de Oliveira VZ; Camargo G; Osório CM; de Castilhos RM; Saraiva-Pereira ML; Schuler-Faccini L; Jardim LB
J Genet Couns; 2012 Feb; 21(1):101-12. PubMed ID: 21717286
[TBL] [Abstract][Full Text] [Related]
12. Preparing for presymptomatic DNA testing for early onset Alzheimer's disease/cerebral haemorrhage and hereditary Pick disease.
Tibben A; Stevens M; de Wert GM; Niermeijer MF; van Duijn CM; van Swieten JC
J Med Genet; 1997 Jan; 34(1):63-72. PubMed ID: 9032652
[TBL] [Abstract][Full Text] [Related]
13. Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.
Cassidy MR; Roberts JS; Bird TD; Steinbart EJ; Cupples LA; Chen CA; Linnenbringer E; Green RC
Alzheimers Dement; 2008 Nov; 4(6):406-13. PubMed ID: 19012865
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease: epidemiology, genetics, and beyond.
Wang XP; Ding HL
Neurosci Bull; 2008 Apr; 24(2):105-9. PubMed ID: 18369390
[TBL] [Abstract][Full Text] [Related]
15. Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives.
Roberts JS
Gerontologist; 2000 Feb; 40(1):43-52. PubMed ID: 10750312
[TBL] [Abstract][Full Text] [Related]
16. Explorative results from multistep screening for potential genetic risk loci of Alzheimer's disease in the longitudinal VITA study cohort.
Scholz CJ; Weber H; Jungwirth S; Danielczyk W; Reif A; Tragl KH; Fischer P; Riederer P; Deckert J; Grünblatt E
J Neural Transm (Vienna); 2018 Jan; 125(1):77-87. PubMed ID: 29027019
[TBL] [Abstract][Full Text] [Related]
17. "Choosing Wisely": Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer's Disease in Dementia Clinics.
Yang HJ; Kang NR; Jung YE; Kim MD; Jeong HG; Lee TJ; Han JW; Kim KW; Park JH
J Alzheimers Dis; 2020; 74(4):1253-1260. PubMed ID: 32176640
[TBL] [Abstract][Full Text] [Related]
18. On the personal utility of Alzheimer's disease-related biomarker testing in the research context.
Bunnik EM; Richard E; Milne R; Schermer MHN
J Med Ethics; 2018 Dec; 44(12):830-834. PubMed ID: 30154216
[TBL] [Abstract][Full Text] [Related]
19. [Predictive testing: presymptomatic diagnosis in neurogenetic disorders].
Dürr A; Gargiulo M; Feingold J
Med Sci (Paris); 2005 Nov; 21(11):934-9. PubMed ID: 16274644
[TBL] [Abstract][Full Text] [Related]
20. The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study.
Ashida S; Koehly LM; Roberts JS; Chen CA; Hiraki S; Green RC
Eur J Hum Genet; 2010 Dec; 18(12):1296-301. PubMed ID: 20664629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
